key: cord-0807485-08s2ys93
authors: Motiejunaite, Justina; Balagny, Pauline; Arnoult, Florence; Mangin, Laurence; Bancal, Catherine; Vidal-Petiot, Emmanuelle; Flamant, Martin; Jondeau, Guillaume; Cohen-Solal, Alain; d'Ortho, Marie-Pia; Frija-Masson, Justine
title: Hyperventilation as one of the mechanisms of persistent dyspnea in SARS-CoV-2 survivors
date: 2021-08-12
journal: Eur Respir J
DOI: 10.1183/13993003.01578-2021
sha: 432bcba78911e89ef406f7844e46b65431bf6974
doc_id: 807485
cord_uid: 08s2ys93

Inadequate exercise hyperventilation should not be overlooked while exploring the causes of exertional dyspnea in SARS-CoV-2 survivors

ORCID ID : 0000-0001-8385-528X

There are increasing reports of persistent dyspnea several months after the onset of severe respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (1) . In most cases, functional disability seems out of proportion compared to residual pulmonary function impairment (2). To this date, knowledge about the functional limitations following a SARS-CoV-2 infection remains limited.

The aim of our study was to evaluate pulmonary, cardiac, and functional capacity of SARS-CoV-2 survivors by performing cardio-pulmonary exercise testing (CPET). We performed a prospective monocentric study of 114 consecutive patients at 3 months (±1 month) after the initial diagnosis of SARS-CoV-2. All patients underwent pulmonary function tests (PFT), chest computed tomography (CCT), trans-thoracic echocardiogram (TTE) as well as symptom-limited CPET. Non-opposition was obtained for all patients, according to French law.

Incremental exercise testing was performed using cycle ergometer (Ergometrics 800S; GE). The peak oxygen uptake (peak V'O 2 ), minute ventilation (V'E) and heart rate were selected as the highest values obtained from any 30-s measurement period. The ventilatory equivalent for carbon dioxide (VE/VCO 2 ) slope was determined using linear regression analysis of V'E and V'CO 2 obtained throughout the exercise period. The Wasserman equation was used to determine the normal predicted peak O 2 value (3), in accordance with recent recommendations (4).

The approach to interpretation of the main exercise limitation was multifactorial and in accordance with current guidelines (4, 5) . Cardiovascular limitation at exercise was defined when one or more of the following criteria were present: evidence of left ventricular systolic or diastolic dysfunction, reduced exercise capacity with low peak VO 2 (<85% of predicted value), reduced oxygen pulse with a flattening curb during incremental exercise, chronotropic insufficiency or reduced peak circulatory power. Respiratory limitation was defined when one or more of the following criteria were present: a significant reduction of pulmonary function at rest as FEV 1 <70% of predicted and/or DLCO <70%, breathing reserve (defined as peak V'E/maximum voluntary ventilation (MVV)) < 30%, or hypoxemia (SpO2 ≤ 88%) during exercise. Peripheral limitation was defined as a reduced peak VO 2 with a premature anaerobic threshold below 40% of predicted in the absence of pulmonary or cardiac limitation. Inadequate exercise hyperventilation was defined as V'E/V'CO 2 slope >40, increased ventilatory equivalents for CO 2 and O 2 as well as higher minute ventilation at anaerobic threshold in the absence of clear pulmonary or cardiac limitation.

The baseline characteristics of enrolled patients are reported in Table 1 . The median age was 57 [48 -66] years and one third were women. 12% of patients had a chronic pulmonary disease such as chronic obstructive pulmonary disease (COPD) or asthma. Most patients (91%) required in-hospital treatment at the onset of the SARS-CoV-2, with 18% of the patients having required mechanical ventilation.

At 3-month follow-up, half of all patients were still symptomatic, dyspnea (40%) and fatigue (32%) being the most common symptoms. 40% of patients had altered diffusion capacity (DLCO) which was mild or moderate in all cases (DLCO > 40% of predicted value (6)). Mild to moderate residual lung involvement on chest CT was found in 65% of patients. TTE showed a normal left ventricular ejection fraction in the majority of the patients as well as a preserved global longitudinal strain. Pulmonary hypertension (systolic pulmonary artery pressure (sPAP) > 40 mmHg) was detected in one patient.

During CPET, 75 % of patients had exercise impairment with peak VO 2 values < 85% of predicted. The median peak VO 2 was 17.9 [14.7 -20.6 ] ml/kg/min. Peripheral deconditioning was the main limiting factor in 43% of patients. 24% of patients had an elevated V'E/V'CO 2 ratio at peak exercise (>40) and 32% had an elevated V'E/V'CO 2 slope (>35). Exercise hyperventilation was the main limitation in 16% of patients. After adjustment for covariates, age (β=0.4, p=0.002), intensive care (ICU) stay (β= -10.27, p=0.017), mechanical ventilation (β=-12.63, p=0.004) and hospital length of stay (β=-0.24, p=0.009) were independently associated with % predicted peak VO 2 .

Patients who had altered diffusion capacity (DLCO ≤ 75%) reached a lower maximal load and had lower VO 2 max values at anaerobic threshold as well as at peak exercise. However, the prevalence of hyperventilation was similar in both groups. Interestingly, patients with reduced DLCO did not report more persistent dyspnea.

The prevalence of exercise limitation in our cohort was much higher than in a study by Rinaldo et al (7) . In accordance with previous report (7), reduced exercise capacity in our cohort was mostly due to peripheral deconditioning. However, our study also found an elevated V'E/V'CO 2 slope in one third of the study participants, suggesting a high incidence of inadequate exercise hyperventilation. Our findings are supported by two previous studies (8, 9) which reported persistent ventilatory inefficiency in smaller cohorts of SARS-CoV-2 survivors who underwent CPET. Increased V'E/V'CO 2 slope and reduced diffusion capacity might suggest pulmonary hypertension at exercise (10) . However, in our cohort only 1 patient had an elevated sPAP at rest. What is more, there was no statistically significant difference in VE/VCO 2 according to DLCO subgroups.

Exercise hyperventilation is a condition characterized by alveolar hyperventilation, which is inappropriate considering metabolic needs and mechanical stress in the body (11) . The origin of this hyperventilation is unknown but may be related to an abnormality of central ventilatory control in the aftermath of pulmonary infection (12) . Increased output of the respiratory centre results in respiratory alkalosis (12) , which in turn activates the autonomous nervous system, causing a variety of neurovegetative symptoms as well as arterial vasoconstriction and hypoperfusion (13) . The diagnosis of hyperventilation syndrome is usually established after exclusion of other cardiopulmonary diseases such as heart failure, asthma or COPD. CPET is useful for the differential diagnosis of dyspnea at exertion. Markers of hyperventilation include increased V'E/V'CO 2 ratio and slope during exercise (14, 15) , rapid increase in ventilatory equivalents for VO 2 and V CO 2 , abnormally high respiratory rate and as well as higher minute ventilation at anaerobic threshold (4). Hyperventilation related symptoms can range from dyspnea, palpitations, chest pain, to dizziness and fatigue that have been reported by the socalled "Covid long-haulers"(1). Identification of hyperventilation syndrome is important because the variety of disabling symptoms might take SARS-CoV-2 survivors to a wide range of specialist consultations, numerous investigations and inappropriate treatment. Whereas respiratory physiotherapy with an experienced therapist with a focus on patient education can help significantly. Spontaneous recovery is also possible.

Our study has several limitations. Firstly, several parameters that could be of interest such as PetCO 2 and individual SpO 2 data were unavailable for statistical analysis. However, none of the patients desaturated at exercise. Moreover, the limitations of reference values for CPET must be taken into account, as % of predicted values are less accurate for obese patients. However, the reference values that were used are in accordance to international guidelines. Another limitation of the study is the absence of arterial blood gas measurement, that would confirm the presence of respiratory alkalosis and thus further strengthen the diagnosis of hyperventilation syndrome. The non-invasive assessment of pulmonary gas exchange during exercise is less reliable and is known to produce higher values of ventilatory equivalents in patients without significant lung disease.

In conclusion, our study confirmed that peripheral deconditioning is the main mechanism of exercise intolerance in the aftermath of SARS-CoV-2. However, exercise hyperventilation should not be overlooked while exploring the causes of dyspnea in SARS-CoV-2 survivors. 

Dr. Vidal-Petiot reports personal fees and non-financial support from Servier, outside the submitted work. Dr. Alain Cohen-Solal has received grants or honoraria from Novartis, Servier, DaiichiSankyo, Vifor, Menarini and Cardiorentis, outside of the submitted work. Dr. Frija-Masson reports non-financial support from Vitalaire, non-financial support from Boehringer Ingelheim, non-financial support from Oxyvie, non-financial support from LVL médical, outside the submitted work. All other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. *BMIbody mass index, NT-proBNP -NT pro brain natriuretic peptide, COPDchronic obstructive pulmonary disease, ICUintensive care unit, VCvital capacity, FEV 1forced expiratory volume in the first second, TLCtotal lung capacity, DLCOdiffusing capacity for carbon monoxide, KCO -carbon monoxide transfer coefficient, CPETcardiopulmonary exercise testing, VO 2oxygen uptake, VE/VCO 2ventilatory equivalent for carbon dioxide, VEpulmonary ventilation, MVVmaximal voluntary ventilation.

Persistent Symptoms in Patients After Acute COVID-19. Jama. 2020. 2. Frija

Principles of Exercise Testing and Interpretation: Including Pathophysiology and Clinical Applications

American College of Chest P. ATS/ACCP Statement on cardiopulmonary exercise testing. American journal of respiratory and critical care medicine

ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseases. European respiratory review : an official journal of the

Interpretative strategies for lung function tests. The European respiratory journal

Deconditioning as main mechanism of impaired exercise response in COVID-19 survivors

Importance of Cardiopulmonary Exercise Testing amongst Subjects Recovering from COVID-19

Cardiopulmonary Exercise Testing to Assess Persistent Symptoms at 6 Months in People With COVID-19 Who Survived Hospitalization -A Pilot Study

Pulmonary Vascular and Right Ventricular Burden During Exercise in Interstitial Lung Disease

Behavioral and Psychological Approaches to Breathing Disorders

Behavioral influences and physiological indices of ventilatory control in subjects with idiopathic hyperventilation. Behavior modification

Hyperventilation: A Possible Explanation for Long-Lasting Exercise Intolerance in Mild COVID-19 Survivors? Frontiers in physiology

Cardiopulmonary exercise testing for identification of patients with hyperventilation syndrome

The values are presented as median [interquartile range] for quantitative variables and as number (percentage) for qualitative variables. Comparisons between groups were performed with unpaired t-tests for normally distributed continuous variables and Mann-Whitney U-tests for non-normally distributed continuous variables

DLCO measurements were available in 111 patients